Search research articles

ACERCA DE JoVE

Visión General Liderazgo Blog Centro de Ayuda JoVE

AUTORES

Proceso de Publicación Consejo Editorial Alcance y Políticas Revisión por Pares Preguntas Frecuentes Enviar

BIBLIOTECARIOS

Testimonios Suscripciones Acceso Recursos Consejo Asesor de Bibliotecas Preguntas Frecuentes

INVESTIGACIÓN

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archivo

EDUCACIÓN

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Centro de Recursos para Profesores Sitio de Profesores

Términos y Condiciones de Uso

Política de Privacidad

Videos de Conceptos Relacionados

Genomics

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...

Genetic Screens

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Behavioral Genetics and Its Designs

Behavioral Genetics and Its Designs

Behavior genetics explores how genetic inheritance influences human behavior. It focuses on how genes, passed from parents to offspring, contribute to the development of behavioral traits and tendencies. This branch of genetics seeks to understand the complex interplay between inherited genetic factors and environmental influences in shaping our behaviors.
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...

Modern Molecular Taxonomy

Modern Molecular Taxonomy

Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por

Same author

PHYSICAL SCIENCE AND THE LIVING ORGANISM.

British medical journal·2010

Same author

THE "BUFFERING" OF BLOOD: A Summary.

British medical journal·2010

Same author

Physiology in horse-racing.

Nature·2010

Same author

Rapid equipment for recording muscle heat.

The Journal of physiology·2010

Same author

The Energy Exchanges in Muscle and Nerve: Samuel Hyde Memorial Lecture.

Proceedings of the Royal Society of Medicine·2009

Same author

MEMBRANE POTENTIALS AND COLLOIDAL BEHAVIOR.

The Journal of general physiology·2009

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Ver todos los artículos relacionados

Search research articles

Video Experimental Relacionado

Updated: Jun 24, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

Inmunogenética y genómica.

¹Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK. adrian.hill@well.ox.ac.uk

Lancet (London, England)

|July 5, 2001

Resumen

Este resumen es generado por máquina.

El análisis inmunogenético revela asociaciones del antígeno leucocitario humano (HLA) con varias enfermedades. Las futuras búsquedas de todo el genoma prometen una visión más profunda del riesgo de enfermedad y nuevos objetivos terapéuticos.

Más Videos Relacionados

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Videos de Experimentos Relacionados

Last Updated: Jun 24, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Área de la Ciencia:

Inmunogenética La inmunogenética.
La genómica es la genómica.
Susceptibilidad a la enfermedad Susceptibilidad a la enfermedad.

Sus antecedentes:

Las asociaciones del antígeno leucocitario humano (HLA) se identifican con numerosas enfermedades de etiología incierta.
Se están aclarando los mecanismos subyacentes a las asociaciones más débiles de HLA con enfermedades infecciosas y no infecciosas.
Se han analizado extensamente las variantes inmunogenéticas no HLA y sus asociaciones con varios genes.

Objetivo del estudio:

Explorar el papel de los factores inmunogenéticos en la susceptibilidad a las enfermedades.
Para resaltar el potencial de los estudios de asociación de todo el genoma en la identificación de genes de riesgo de enfermedad.
Subrayar la promesa de la inmunogenómica para comprender la patogénesis de las enfermedades y desarrollar intervenciones.

Principales métodos:

Análisis de las asociaciones del antígeno leucocitario humano (HLA).
Investigación de las variantes inmunogenéticas no HLA.
Análisis del enlace genético en familias multicasadas.
Búsqueda de genes de susceptibilidad en todo el genoma.

Principales resultados:

Asociaciones de HLA fuertes y más débiles identificadas con diversas enfermedades.
Asociaciones encontradas entre variantes inmunogenéticas no HLA y genes específicos.
Se identificaron nuevos loci principales de susceptibilidad para enfermedades comunes inmunológicamente determinadas.
Identificación de los efectos acumulativos de genes con impactos individuales modestos en el riesgo de enfermedad.

Conclusiones:

El análisis inmunogenético, en particular las búsquedas de todo el genoma, ofrece un potencial significativo para comprender la patogénesis de la enfermedad.
Este enfoque puede identificar múltiples objetivos moleculares para futuras estrategias de intervención.
El campo de la inmunogenómica está preparado para proporcionar información clave sobre enfermedades complejas.